2023-04-04 03:44:22 ET
- Biopharmaceutical company, Supernus Pharmaceuticals ( NASDAQ: SUPN ) has paid out the total principal amount due of $402.5M under its 0.625% convertible senior notes due 2023.
- This is in addition to payment of the remaining outstanding interest due of $1.3M. With the repayment, 2023 notes are no longer outstanding.
- The repayment was financed primarily with available cash on hand and, to a lesser extent, through a borrowing under the company’s existing credit line agreement.
For further details see:
Supernus Pharmaceuticals pays out $402M senior convertible notes